Using Antibiotics to Prevent Infections in Hemodialysis Patients During Catheter Placement

PHASE4RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 28, 2024

Primary Completion Date

December 30, 2027

Study Completion Date

June 30, 2028

Conditions
Infection Catheter-Related
Interventions
DRUG

• Cefamezine (2 grams) and gentamicin (80 mg) administered intravenously. • Patients with penicillin allergies, a history of methicillin-resistant Staphylococcus aureus (MRSA) infection, or known MRSA

"Patients with an elevated risk of infection will be randomly assigned to two groups using stratification for new catheter placement versus catheter replacement. Fifty percent of the high-risk patients will receive prophylactic antibiotics targeting gram-positive and gram-negative bacteria. The antibiotic regimen will include:~* Cefamezine (2 grams) and gentamicin (80 mg) administered intravenously.~* Patients with penicillin allergies, a history of methicillin-resistant Staphylococcus aureus (MRSA) infection, or known MRSA colonization will receive vancomycin (2 grams)."

Trial Locations (1)

2210001

RECRUITING

Galilee Medical Center, Nahariya

All Listed Sponsors
lead

Western Galilee Hospital-Nahariya

OTHER_GOV

NCT06814223 - Using Antibiotics to Prevent Infections in Hemodialysis Patients During Catheter Placement | Biotech Hunter | Biotech Hunter